Should you buy CVS Health stock now?
No, the technical signal for CVS Health is currently Sell. CVS Health trades at $83.85 as of Nov 7, 2026. The technical analysis shows the following: MACD is negative (bearish trend) at -1.435 with falling momentum (signal: -0.399); RSI is at 40.5 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $115.52 points to 37.8% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for CVS Health stock?
The average analyst price target for CVS Health is $115.52. The current price is $83.85, which gives an upside of 37.8%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $103.97 and $127.07.
Is CVS Health a dividend stock?
Yes, CVS Health is a dividend stock with a dividend yield of 3.33%. The payout ratio is 31.9%, which is considered sustainable.
What is the risk of CVS Health stock?
CVS Health is rated as a stock in the risk category Moderate. the annual standard deviation is 37.8%, which classifies the stock as Moderate.
Is CVS Health overvalued?
No, CVS Health is considered undervalued based on the analyst price target (37.8% upside). CVS Health has the following valuation ratios: a P/E ratio of 9.4 (lowly valued), a P/S ratio of 0.2, a P/B ratio of 1.3. The analyst price target suggests that the stock is undervalued by 37.8%.
Is CVS Health overbought?
No, CVS Health is not overbought. RSI is at 40.5 (neutral zone). The technical indicators show: RSI is at 40.5 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 6.5% below the 20-day average (short-term downtrend). In addition, MACD is negative with falling momentum (bearish).
When is the next CVS Health earnings report?
The date of the next earnings report for CVS Health has not been published yet. Check the company's investor calendar for updates.
Is CVS Health shorted?
Yes, CVS Health is shorted with 1.3% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying CVS Health stock?
Yes, insiders are net buyers of CVS Health – they are buying more shares than they are selling. Over the last 3 months, insiders have made 1 purchases and 0 sales. On a net basis, 2,001,435 $ worth of shares were bought. Across the last 20 reported transactions, the split is 10 purchases and 10 sales, with a net 515,350,207 $ sold. Active buyers include Shah Prem S, SANSONE GUY P, Mahoney Michael F and others. In our study of insider purchases, however, the typical purchase did not beat the market over the following 3 months.
Is CVS Health a good stock?
Based on our total score, CVS Health is rated as a good stock with a total score of 68 out of 100. The stock scores above average on value, quality and momentum. The score is made up of Value: 94/100, Quality: 61/100, Momentum: 50/100. In addition: analysts see 37.8% upside to the price target; a dividend of 3.33%. Whether now is the time to buy is a separate question: the technical signal is Sell. Whether CVS Health is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for CVS Health stock?
The outlook for CVS Health based on current data: the average analyst price target is $115.52 (+37.8%); the stock is in a downtrend (below SMA50 and SMA200); the P/E ratio is 9.4 (low – a possible value stock). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is CVS Health stock falling?
CVS Health is falling right now. The technical indicators show: the price is 6.5% below the 20-day average; MACD is negative with falling momentum (bearish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can CVS Health go?
The average analyst price target for CVS Health is $115.52, which corresponds to a potential gain of 37.8% from the current price of $83.85. The stock has traded between $67.99 and $109.22 over the last 52 weeks. The price is 23.2% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can CVS Health fall?
The stock has traded as low as $67.99 over the last 52 weeks — that is 18.9% below the current price of $83.85. The biggest decline (drawdown) in the same period was 37.7% from high to low. Within a year, the price typically swings about ±37.8% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does CVS Health do?
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medica... The company belongs to the Healthcare sector, more specifically the Healthcare Plans industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate CVS Health as an investment.
Did CVS Health raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from CVS Health. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is CVS Health making money or losing money?
Yes, CVS Health is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 2.6% — which is modest. The operating margin (profit before interest and taxes) is 3.3%. At a P/E ratio of 9.4, you currently pay 9.4 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can CVS Health go bankrupt?
The bankruptcy risk of CVS Health is rated as moderate. Altman Z2 (a model for assessing financial distress) is 1.37 — that places the company in the middle zone. The Piotroski score (financial health 0-9, higher is better) is 8 — which is strong. Debt relative to equity is 235% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does CVS Health have a lot of debt?
Yes, CVS Health has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 235%. For the healthcare sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can CVS Health service its debt? Can service its debt, but it weighs on the company — the interest coverage ratio (how many times earnings can cover interest payments) is 4.8x, and net debt equals 3.3 years of earnings (EBITDA).